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Pyrrolizidine alkaloids (PAs) are widely occurring phytotoxins which can induce severe liver 
damage in humans and other mammalian species by mechanisms that are not fully 
understood. Therefore, we investigated the development of PA hepatotoxicity in vivo, using 
an acutely toxic dose of the PA senecionine in mice, in combination with intravital two-photon 
microscopy, histology, clinical chemistry, and in vitro experiments with primary mouse 
hepatocytes and liver sinusoidal endothelial cells (LSECs). We observed pericentral LSEC 
necrosis together with elevated sinusoidal marker proteins in the serum of senecionine-
treated mice and increased sinusoidal platelet aggregation in the damaged tissue regions. In 
vitro experiments showed no cytotoxicity to freshly isolated LSECs up to 500 µM 
senecionine. However, metabolic activation of senecionine by preincubation with primary 
mouse hepatocytes increased the cytotoxicity to cultivated LSECs with an EC50 of 
approximately 22 µM. The cytochrome P450 (CYP)-dependency of senecionine bioactivation 
was confirmed in CYP reductase-deficient mice where no PA induced hepatotoxicity was 
observed. Therefore, toxic metabolites of senecionine are generated by hepatic CYPs, and 
may be partially released from hepatocytes leading to destruction of LSECs in the pericentral 
region of the liver lobules. Analysis of hepatic bile salt transport by intravital two-photon 
imaging revealed a delayed uptake of a fluorescent bile salt analogue from the hepatic 
sinusoids into hepatocytes and delayed elimination. This was accompanied by transcriptional 
deregulation of hepatic bile salt transporters like Abcb11 or Abcc1.  
In conclusion, senecionine destroys LSECs although the toxic metabolite is formed in a CYP-










3-MC, 3-methylcholanthrene; ALT, alanine transaminase; AST, aspartate transaminase; AU, 
arbitrary unit; AUC, area under the curve; BC, bile canaliculi; BW, body weight; LE, liver 
extract; CLF, cholyl-lysyl-fluoresceine; CYP, cytochrome P450 monooxygenase(s); GFP, 
green fluorescent protein; CV, central vein; HE, hematoxylin eosin staining; KH buffer, Krebs-
Henseleit buffer; LSEC, liver sinusoidal endothelial cells; NPC, non-parenchymal cells; PI, 
propidium iodide; PA(s), pyrrolizidine alkaloid(s); PMH, primary mouse hepatocytes; POR, 
NADPH-cytochrome P450 reductase; t1/2, half-life; tmax, time to maximum; TMRE, 





More than 660 different PAs have been identified, about half of them are known to be 
hepatotoxic (Fu et al. 2004; Stegelmeier et al. 1999). Plants typically contain mixtures of 
PAs, of which the 1,2-unsaturated form, like senecionine, exhibits the strongest hepatotoxic 
properties. Their genotoxicity and carcinogenicity are based on the metabolic activation of 
1,2-unsaturated PAs to highly reactive, electrophilic pyrrole derivatives by cytochrome P450 
(CYP) monooxygenases (Fu et al. 2004). Human exposure to PAs predominantly occurs 
through consumption of PA-containing plants, food prepared from PA-contaminated 
materials, tea, and honey (Bodi et al. 2014; Mulder et al. 2015). Epidemic PA poisoning 
occurred in central India in 1975 due to the consumption of millet contaminated with seeds of 
Crotalaria species. Around 8000 individuals were affected by Heliotropium popovii 
contamination of bread in 1975/1976 in Afghanistan, with 3000 severe intoxications and a 
relatively high mortality rate. Another outbreak of hepatic VOD due to the consumption of 
Heliotropium popovii-contaminated bread occurred 2008 in Afghanistan (Kakar et al. 2010). 
Typical histological consequences of PA intoxication are centrilobular hemorrhagic necrosis 
and fibrosis, and veno-occlusive disease (VOD). Clinical symptoms accompanying VOD 
comprise ascites, edemas, hepatomegaly, emaciation and an increase of blood bilirubin 
levels which may result in jaundice (Mohabbat et al. 1976; Tandon et al. 1978; WHO 1988).  
A number of publications (Luckert et al. 2015; Waizenegger et al. 2018; Yang et al. 2016) 
have analyzed the impact of PAs on hepatocytes, the most abundant hepatic cell type and 
main target of most hepatotoxins. Analyses of PA-treated human primary hepatocytes 
identified numerous hepatotoxic pathways like hepatic steatosis, cholestasis, hepatomegaly, 
inflammation and cancer associated signaling pathways as affected by PA exposure (Luckert 
et al. 2015). Many studies also showed PA cytotoxicity and the induction of apoptosis in vivo 
and in vitro in different cell systems (Copple et al. 2004; Ebmeyer et al. 2019c; Gordon et al. 
2000; Steenkamp et al. 2001; Waizenegger et al. 2018). However, VOD as a typical marker 
of PA poisoning also suggests the induction of effects in other cell types than hepatocytes, 
especially in endothelial cells (Chen and Huo 2010; DeLeve et al. 2002). Based on a rat VOD 
model using the PA monocrotaline, it has been suggested that endothelial cells round up, 
detach, and finally embolize to block the microcirculation (DeLeve et al. 2002). However, the 
molecular mechanisms responsible for this key event remain unclear. In vitro data suggest 
that endothelial cells may be more susceptible to reactive PA intermediates and this 
difference may be related to the lower levels of the important scavenger glutathione (Yang et 
al. 2016). Accordingly, glutathione infusion was shown to prevent hepatotoxicity of the PA 
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monocrotaline (Wang et al. 2000). Moreover, matrix metalloproteinases appear to be 
involved in PA toxicity in endothelial cells (Deleve et al. 2003b).  
Many details of PA-dependent hepatotoxicity have not been elucidated yet in depth, 
especially with respect to the mechanisms of VOD development. Therefore, the present 
study was designed to address three key questions, namely to unravel the mechanisms by 
which senecionine induces cholestasis, to elucidate whether the in vivo hepatotoxicity of 
senecionine is CYP-dependent, and to determine how the liver sinusoidal endothelial cells 
are affected by the compound. 
2 Material and methods 
2.1 Animals and materials 
All animals and materials used in this study are summarized in table S1 in the supplemental 
material. 
2.2 Animal study and sample collection 
Intravital imaging and hepatotoxicity studies were performed using male C57BL/6NRj mice. 
In addition, Tie2 reporter mice were used for the visualization of the sinusoidal cells and 
platelets in intravital imaging. These mice were derived from mating Tie2Cre mice (Koni et al. 
2001) with mT/mG mice (Muzumdar et al. 2007) expressing eGFP in the target cells. To test 
for cytochrome P450 (Cyp)-dependent bioactivation of senecionine, endogenous reductase 
locus (ERL) mice were used. These mice carry a floxed NADPH-cytochrome P450 reductase 
(POR) and Cre recombinase under the control of the Cyp1a1 promoter. POR-knockout was 
induced by intraperitoneal (i.p.) injection of 4 mg per kg BW of the Cyp1a1 inducer 3-
methylcholanthrene (3-MC) 10 days prior to senecionine administration (Henderson et al. 
2015). For all experiments male mice were used at the age of 8 to 10 weeks. Animals were 
housed with 12 h light-dark cycle and provided ad libitum access to water and standard 
mouse diet (Ssniff, Soest, Germany). All animal experiments were approved by the local 
authorities (LANUV, Recklinghausen, Germany). All details for treatment of animals, 
quantitative analysis of histological staining, the pharmacokinetic analyses of cholyl-lysyl-
fluoresceine (CLF) elimination, the immunohistochemistry and Western blotting, as well as 
the isolation of RNA and quantitative real-time PCR are described in detail in the 
supplementary material.  
2.3 Intravital imaging 
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Intravital imaging was performed according to a previously published procedure (Reif et al. 
2017). In brief, Hoechst 33258 and propidium iodide (PI) were injected into anesthetized 
mice via the tail vein. C57BL/6NRj mice additionally received tetramethylrhodamine ethyl 
ester (TMRE). A small midline incision was introduced in the upper abdomen and the 
falciforum ligament was cut to expose the left liver lobe. The mouse was laterally placed onto 
a 0.17 mm thick cover slip (Logitech Limited, Glasgow, UK) in a custom-made platform. For 
the online injection of CLF a lateral tail vein was catheterized (SAI Infusion Technologies, 
Lake Villa, USA). Images were acquired using a custom-modified inverted LSM MP7 (Zeiss, 
Göttingen, Germany) with LD C-Apochromat 40 x 1.1 water immersion objective (Zeiss, 
Göttingen, Germany). During imaging the animal was kept under 0.5-1 % isoflurane with an 
evaporator (Foehr Medical Instruments, Seeheim-Jungenheim, Germany) and maintained at 
37° C in an incubation chamber (Solent Scientific, Porthsmouth, UK). For two-photon 
excitation, a Chameleon Ultra II laser (Coherent, Gilching, Germany) tuned to 780 nm was 
used. The blue fluorescence was collected in a NDD detector using the shortpass filter 485, 
the green and the red fluorescence were collected in a GaAsP detector with the bandpass 
filters 500-550 and 565-610, respectively. Imaging was performed with a dwell time between 
1 and 3 µs and a frame rate of 5-15 s per scan. 
2.4 Senecionine toxicity in vitro 
Primary mouse hepatocytes (PMH) were isolated as described previously (Reif et al. 2015). 
In brief, the liver of a C57BL/6NRj mouse was initially perfused with EGTA buffer (Krebs-
Henseleit (KH) supplemented with 0.51 mM EGTA, pH 8.2) and subsequently changed to 
collagenase buffer (KH buffer with 5.1 mM CaCl2, 45.5 U collagenase per ml (#C2674, 
Sigma Aldrich, Taufkirchen, Germany), pH 8.2). After perfusion, the liver was dissected and 
gently dissociated in suspension buffer (KH buffer supplemented with 1.05 mM CaCl2, 0.4 
mM MgSO4, 2 % BSA, pH 7.4). The resulting cell suspension was first filtered through a 
strainer (pore size 100 µm) and centrifuged at 50 x g for 5 min at 4°C. The pellet contained 
the PMH fraction. The supernatant was centrifuged again at 400 x g for 10 min at 4° C to 
pellet the non-parenchymal cell (NPC) fraction. Both pellets were resuspended in 
suspension buffer. 150,000 PMHs or 1.5 million NPCs were seeded per well in a 4-well µ-
slide chamber pre-coated with a collagen IV (Ibidi, Martinsried, Germany) in cultivation 
medium (Williams E medium, PAN Biotech) supplemented with 2 mM glutamine, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 10 µg/ml gentamycin (all PAN Biotech, Aidenbach, 
Germany), 100 nM dexamethasone, 20 ng/ml bovine insulin (both Sigma Aldrich, 
Taufkirchen, Germany), 50 ng/ml murine EGF (R&D Systems, Minneapolis, USA) and 10 % 
sera plus (PAN Biotech, Aidenbach, Germany). After 3 h of attachment, medium was 
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changed to serum-free cultivation medium containing senecionine in concentrations 
between 0 and 500 µM. In case of a medium transfer, the supernatants of the PMH 
cultures were transferred to the corresponding NPC cultures after 6 h. Cells were treated 
for 2 days before the CellTiter-Blue viability assay (Promega, Mannheim, Germany) was 
performed according to the manufacturer’s instructions. The PMH and the NPC cultures 
were incubated with the fluorogenic substrate for 1 h or 5 h, respectively. The resulting 
fluorescence intensity was measured with an Infinite M200 Pro plate reader (Tecan, Tecan 
Group, Maennedorf, Switzerland) at 540 nm for excitation and 594 nm for emission. 
2.5 Statistical analysis 
Significant differences between mean values in a concentration- or time-series were 
calculated by one-way analysis of variance (ANOVA) followed by Dunnett’s post-hoc test 
versus the corresponding control or the time point 0 h. Scenarios including two variables 
were analyzed by two-way ANOVA (gene expression analysis) or two-way ANOVA followed 
by Holm-Sidak post-hoc test (kinetic parameters). Comparison of mean values between two 
groups was analyzed by Student’s t-test. Normal distribution was assumed for all data. 





3.1 LSEC necrosis, hemorrhage, and platelet aggregation are characteristics of 
 senecionine intoxication 
In order to gain a better understanding of the mechanisms underlying the hepatotoxicity of 
PAs, we used senecionine as a representative test compound. Senecionine is one of the 
most frequently occurring PA in tea samples (Bodi et al. 2014) also exhibiting high potency to 
induce strong toxicity (Merz and Schrenk 2016). Initially, time- and dose-dependent 
hepatotoxicity of senecionine was analyzed in C57BL/6NRj mice. Both liver diagnostic 
markers ALT and AST emerged in blood 18 h after oral administration of 60 mg senecionine 
per kg BW and increased notably over the investigated time (Fig 1A). After 30 h clinical 
symptoms of the senecionine-treated mice were evident. Pericentral necrosis was first 
observed 18 h after senecionine administration in HE-stained liver sections and increased up 
to a dead cell area of approximately 75 % after 34 h, extending in some mice into the 
midzonal lobular region (Fig. 1A, right panel). In a dose-dependent experiment, markers of 
hepatotoxicity were unchanged in animals with 15 mg/kg BW after 30 h compared to control 
animals (Supporting Fig. S1A-C). Higher doses up to 60 mg/kg led to constantly increasing 
ALT and AST levels. Similarly, in histopathology approximately 20 % of the pericentral region 
was necrotic with 45 mg/kg BW after 30h, reaching 65 % with 60 mg/kg BW. Hence, we 
chose 60 mg senecionine per kg BW to study senecionine-induced hepatotoxic effects in 
more detail. The observations described above were corroborated by findings at the gene 
expression level, demonstrating a senecionine-dependent loss of expression of genes 
expressed in the pericentral lobular zone, such as Cyp1a2, Cyp2e1, Axin2, Lgr5, and 
Cyp7a1 (Fig. 2). Intravital two-photon microscopy (Denk et al. 1990; Helmchen and Denk 
2005) was used for the first time to study PA hepatotoxicity in mouse liver. The Tie2 reporter 
mouse which expresses red fluorescent membrane-bound tdTomato in hepatocytes as well 
as green fluorescent membrane-bound GFP in sinusoidal cells, platelets, and immune cells 
was chosen in order to differentiate between the liver cell types (Constien et al. 2001). 
Fluorescence microscopy of livers from senecionine-treated Tie2 reporter mice revealed a 
remarkable pericentral loss of liver sinusoidal endothelial cells (LSECs) 30 h after intoxication 
(Fig. 1B). Immune cell infiltration into the tissue accompanied LSEC depletion (Fig. 1B right). 
Accordingly, a time- and dose-dependent induction of the inflammation-related mRNAs for 
Lcn2, Mt2 and Saa3 were observed (Fig. 2). Hepatic hemorrhage was detected in the 
pericentral region from 18 h on, while the area of hemorrhage extended gradually over the 
investigated time of 24 h (Fig. 1C). Moreover, transient aggregation of platelets occurred 
more frequently in senecionine exposed mice than in controls during in intravital imaging of 
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Tie2 reporter mice (Fig. 1D, Supporting Video 1 and 2). Three-dimensional reconstruction of 
liver sinusoids was used to illustrate the pericentral LSEC loss (Fig. 1E). The intravital 
recordings clearly show the zone-specific pericentral degeneration of LSECs as a 
fundamental early effect of senecionine intoxication. Tissue hemorrhage and platelet 







Fig. 1. Toxic effects induced by senecionine in mouse liver. (A) Administration of 60 mg senecionine 
per kg BW resulted in increasing AST and ALT serum levels associated with marked tissue necrosis. 
(B) Specific loss of pericentral LSECs (arrowheads) in senecionine-treated Tie2 reporter mice 
compared to control animals (left), accompanied by infiltration of immune cells (arrows). (C) Histology 
of senecionine-treated mice showed pericentral hemorrhage which extended over time. (D) Intravital 
imaging of Tie2 reporter mice illustrated transient platelet aggregation (arrows). See also Supporting 
Video 1 for senecionine-treated mouse and Supporting Video 2 for control Tie2 reporter mouse. (E) 
Sinusoidal reconstruction of control and senecionine-treated mice (time point 24 h) demonstrates 
LSEC loss in the pericentral region. (F) Lyve-1 was identified as a serum marker for LSEC destruction 
in senecionine-treated mice (LE, liver tissue extract from freshly isolated untreated mouse). Statistical 
relevance was determined using ANOVA followed by Dunnett’s post-hoc test against t = 0 h with p-
values as follows: *< 0.05, **<0.01, ***<0.001. 
 
Fig. 2. Influence of senecionine on 
hepatic gene expression. Expression 
of hepatic genes involved in bile acid 
homeostasis, WNT signaling and 
inflammatory response was affected. 
Senecionine mainly caused a 
concentration-dependent decrease in 
expression of bile acid homeostasis 
associated genes with overall lowest 
mRNA levels at the highest tested 
dose (60 mg/kg BW) after 24 h with a 
simultaneous increase of the 
inflammatory response. Both effects 
may be associated with the dose-
dependent induction of pericentral 
necrosis. Relative mRNA gene 
expression values are expressed as 
means with n=5 for 6h, 12h and 24h 
treatment with 30 mg/kg BW and 6 h 
treatment with 45 mg/kg BW or n=4 
for remaining treatments. Statistical 
relevance was determined two-way 
ANOVA with p-values as follows: * < 
0.05, ** < 0.01, *** < 0.001 (*, time 
dependence; 
#
, dose dependence). 
Relative gene expression below -15 




3.2 Metabolic activation of senecionine by Cyps is a precondition of LSEC 
destruction  
Intoxications caused by xenobiotics often result from their metabolic activation by 
cytochrome P450 (Cyp) enzymes in hepatocytes (Park et al. 2005). Therefore, we addressed 
the question next whether the toxic effect of senecionine on LSECs originates from the 
parental compound or from active metabolites. To study the impact of Cyp-mediated 
metabolism on senecionine toxicity, mice deficient in hepatic NADPH-cytochrome P450 
oxidoreductase (POR) which in the active state mediates the electron transfer from 
NADPH/H+ to Cyp was utilized. Deficiency in POR results in a strongly reduced activity of 
Cyp. HE-stained liver sections from (3-MC-treated) POR-knockout mice that were exposed to 
60 mg senecionine per kg BW for 36 h were identical to the control sections of the untreated 
mice (Fig. 3A) Accordingly, the levels of the diagnostic markers ALT and AST in the blood of 
POR-knockout mice were not elevated compared to solvent-treated animals (Fig. 3B). In 
contrast to C57BL/6NRj mice, senecionine did not cause necrotic areas or signs of tissue 
hemorrhage in mice with POR deletion. These results indicate that senecionine requires 
metabolic activation to induce its toxic effect.  
Subsequent in vitro experiments with primary mouse hepatocytes (PMH) and primary LSECs 
were conducted to study whether the LSEC-harming compound originates from Cyp-
mediated metabolism in the hepatocytes. Isolated LSECs (NPCs) displayed no signs of 
toxicity when exposed to non-metabolized senecionine in concentrations up to 500 µM (Fig. 
3C, red). In contrast, PMH showed a concentration-dependent decrease in viability 
throughout the tested senecionine concentrations with an EC50 value of 26 µM (Fig. 3C, 
blue). NPCs exposed to PMH-conditioned senecionine-containing medium showed a similar 
toxic response as the PMH cultures, with an EC50 of 22 µM (Fig. 3C, green). Moreover, 
senecionine had no effect on the viability of PMH derived from POR-knockout mice up to a 
concentration of 200 µM; only upon exposure to 500 µM the viability of POR-knockout PMH 
decreased to approximately 60 % (Fig. 3C, black). These findings demonstrate that 
senecionine is metabolically activated by Cyps in hepatocytes and the resulting metabolite(s) 




Fig. 3. Senecionine toxicity is cytochrome P450 reductase-dependent and affects hepatocytes and 
LSECs. (A) ERL mice induced with MC for POR-knockout (POR KO) showed no liver necrosis after 60 
mg senecionine per kg BW administration in contrast to C57BL/6NRj mice. (B) ALT, AST, and bile acid 
serum levels in POR-knockout mice were similar to control levels. (C) PMHs from wt mice showed a 
concentration-dependent decrease in viability with increasing senecionine concentrations up to 500 
µM (blue), while isolated LSECs (wt) were not affected by senecionine in the tested concentrations 
(red). LSECs cultivated in senecionine conditioned medium derived from PMHs lost viability similarly 
as wt hepatocytes (green). PMHs from POR KO mice were resistant to senecionine up to a 
concentration of 200 µM (black). Statistical significance was determined using ANOVA followed by 
Dunnett’s post-hoc test against t = 0 h with p-values *< 0.05, **<0.01, ***<0.001 (C) or student´s t-test 
with p-values *< 0.05, **<0.01 (treatment vs control in respective mouse strain). 
 
3.3 Mice exposed to senecionine develop cholestasis 
Bile acid concentrations in blood were elevated 18 h after senecionine administration and 
further increased at later time points (Fig. 4A). In contrast, ERL mice with POR-knockout 
showed similar bile acid concentrations compared to control animals. Tracing the transport of 
the bile salt analogue CLF was used to determine the kinetic differences of bile acid uptake 
and excretion between control and senecionine-treated mice in vivo. Before recording the 
nuclear marker Hoechst 33258, the nuclear marker PI, and the mitochondrial potential 
marker TMRE were injected (Fig. 4B). 
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In control mice, CLF was detected in the sinusoids approximately 0.2 min after injection. 
Next, CLF was enriched at the margin between sinusoidal endothelial cells and hepatocytes 
(Fig. 3B, 0.5 min), which probably represents the space of Disse, followed by enrichment in 
hepatocytes throughout the entire liver lobule approximately 1.5 min post injection with 
higher intensity of the signal in the pericentral region (Fig. 4B upper, Supporting Video 3). 
Intracellular CLF was then exported into the bile canaliculi where it reached maximal intensity 
between 1 and 10 min after injection min. Approximately 12.5 min after injection, 
fluorescence of CLF was exclusively present in bile canaliculi, and to a large part eliminated 
from the liver. The CLF signal was almost completely cleared from the liver of the control 
mice approximately 60 min after tail vein injection.  
The kinetics of CLF uptake and transport into the hepatocytes and bile canaliculi were 
altered upon senecionine treatment (Fig. 4B bottom, Supporting Video 4). Only few PI 
positive cells were observed in the pericentral region (arrow). The half-life of CLF in the 
sinusoids was prolonged and a lack of the transient enrichment in the pericentral sinusoidal 
cells compared to control mice was observed. Transport of CLF from the hepatocytes into 
the bile canaliculi was strongly delayed in the pericentral hepatocytes. Bile canaliculi 
appeared widened especially in the pericentral region (arrowheads). CLF enriching 
hepatocytes with positive nuclear PI staining failed to excrete CLF into bile canaliculi. 
In summary, senecionine caused a delay of CLF uptake from the sinusoids and excretion 
into the canaliculi resulting in increased bile acid concentrations in all compartments of the 
liver lobule, as quantified by CLF fluorescence (Fig. 4C) and subsequently calculated kinetic 
parameters Tmax, AUC, and T1/2 (Fig. 4D). 
At the gene expression level, significant alterations in mRNA expression related to bile acid 
synthesis, metabolism and transport were detected after exposure to senecionine (Figure 2): 
Expression of several solute carrier-class transporters (Slco1b2, Slc10a1, Slc22a7, 
Slc22a21) involved in bile acid uptake into hepatocytes was reduced, and similar 
observations were made for ABC transporters involved in bile acid excretion (Abcb1, 
Abcb11, Abcb4, Abcc2, Abcc4). However, Abcc1 involved in bilirubin and conjugated bile salt 
excretion was identified to be time-dependent significantly up-regulated (supplemental 
material Fig. S2). Expression of genes associated with the of bile homeostasis was 
significantly downregulated after treatment with 60 mg senecionine per kg BW at 24 h. 




Fig. 4. Senecionine intoxication causes cholestasis. (A) Elevated bile acid concentrations were 
detected in the blood of C57BL/6NRj mice 18 h after administration of 60 mg senecionine per kg BW. 
(B) Bile acid transport is delayed in senecionine-treated mice. The stills from intravital imaging videos 
show hepatic clearance of the green fluorescent bile salt analogue CLF of a control mouse (upper, see 
also Supporting Video 3) and a senecionine-treated mouse after 24 h (bottom, see also Supporting 
Video 4). The arrow depicts dead cells, with positive nuclear PI staining; arrowheads indicate widened 
BC. (C) Time-resolved quantification of CLF fluorescence progressing from the sinusoids, into 
hepatocytes and BC. Quantification differentiates between the pericentral and periportal regions of 
liver lobules. CLF clearance of control (solid line) and senecionine-treated animals (dashed line) is 
shown for one representative mouse, while data of all analyzed mice are given in the table (D). (D) 
Table of the determined kinetic parameters time of maximum Tmax, AUC, and the elimination rate T1/2 
of CLF fluorescence in the different compartments of the liver, comparing control and senecionine-
treated animals. Data are mean values and SD of 5 mice. Statistical significance was determined 






The present study provides for the first time, real-time insight into hepatotoxic injury caused 
by PAs. Early pericentral destruction of LSECs in VOD development and dependence of this 
process on metabolic activation of the PA senecionine by hepatic Cyp enzymes was 
demonstrated in vivo. Naturally occurring 1,2-unsaturated PAs can induce severe liver 
damage in humans and livestock. Case reports, e.g. from a six-month-old girl who was 
diagnosed with hepatic VOD progressing to sinusoidal liver fibrosis and cirrhosis, show that 
an intake of 0.8-1.7 mg PAs per kg BW per day for two weeks was sufficient to induce VOD 
(Stillman et al. 1977; WHO 1988). A two-month-old boy ingested 3 mg PAs per kg body 
weight per day and died after 6 days with pronounced centrilobular hemorrhagic necrosis of 
the liver (Fox et al. 1978; WHO 1988).  
Single senecionine doses used in the present mouse study caused acute hepatotoxicity; the 
highest dose (60 mg/kg BW) is two to six-times higher compared to the doses reported in the 
case studies of the above-mentioned intoxicated infants who were exposed in sum over the 
whole short period of one or two weeks to 11 to 25 mg PAs per kg BW. Reported clinical 
outcomes are comparable between intoxicated mice and human infants comprising the 
development of severe liver damage including centrilobular necrosis, and the disturbance of 
bile acid homeostasis which is reflected by jaundice in humans (Fox et al. 1978; Stillman et 
al. 1977; WHO 1988). In the case report by Datta et al. (1978) two patients developed 
jaundice, abdominal pain, ascites, gastrointestinal bleeding and hepatic encephalopathy after 
an estimated daily intake of 3.3 mg of the PA heliotrine per kg BW for 20 or 50 days. Death 
occurred in the second week or within 12 weeks, respectively (Datta et al. 1978). However, 
such severe intoxications do not occur frequently. Based on recent data collected in the EU, 
an estimate upper bound exposure of 820.5 ng PAs per kg BW per day (95th percentile 
exposure, mean value 310.8 ng/kg BW per day) was calculated for toddlers (EFSA 2016). 
The chronic exposure to PAs in middle Europe is estimated to range between 34.5 to 48.4 ng 
per kg BW per day in the young population and between 31.1 to 41.8 ng per kg BW per day 
in the adult population, with PA-contaminated tea being the main source of exposure (EFSA 
2016).  
The toxicity of PAs depends on their metabolism in the liver where they can either be 
metabolically activated or detoxified. Hydrolysis into water-soluble free necine acids and 
bases and N-oxidation of the parent compounds represent the detoxification routes. CYP-
dependent dehydrogenation of the pyrrolizidine ring can lead to the conversion of non-
cleaved esters into toxic pyrrole derivatives (dehydropyrrolizidine esters). Pyrrole derivatives 
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are highly reactive alkylating agents capable of binding to nucleic acids and proteins. They 
can also react with nucleophilic biomolecules after hydrolysis to dehydronecine. As a result 
of adduct formation, hepatotoxic, carcinogenic and mutagenic effects may occur (Ebmeyer et 
al. ; Ruan et al. 2014). Our results showed for the first time that the induction of toxic effects 
in hepatocytes and LSECs clearly depends on the direct Cyp-mediated activation of 
senecionine in vivo, as already suggested for PAs like senecionine or lasiocarpine in vitro 
(Ebmeyer et al. 2019a; Ebmeyer et al. ; Ruan et al. 2014). The specific metabolism-
dependent destruction of the LSECs was observed in vivo using POR-knockout mice and the 
in vitro approach demonstrating cytotoxicity on LSEC only after metabolic activation of 
senecionine using PMH supernatant. The strong toxicity of the metabolized senecionine 
observed in this study may be associated with a significant depletion of glutathione as 
reported to occur during the development of the VOD. The continuous administration of 
glutathione prevents the development of PA-induced VOD in a rat model, and it is therefore 
assumed that glutathione depletion plays an important role in the development of VOD 
(DeLeve et al. 2003a; Helmy 2006).  
The development of jaundice has often been reported in the context of PA intoxication (Fox 
et al. 1978; Gao et al. 2012; Stillman et al. 1977; WHO 1988). The present study showed that 
bile acid concentrations increased after senecionine intoxication in mice. This effect was 
shown to be Cyp-dependent (Fig. 4A). A comparable increase of bile acids in serum of rats 
was also observed after oral administration of senecionine and a PA cocktail isolated from 
Senecio vulgaris (Xiong et al. 2014). Also, other case studies of intoxicated livestock showed 
an increase of bile acids in serum and enhanced bilirubin after ingestion of PA-containing 
plants (Baker et al. 1991; Mendel et al. 1988; Stegelmeier et al. 1996). Increased serum bile 
acids may be associated with excessive secretion of bile acids from the liver due to bile acid 
overload in hepatocytes as observed in mouse hepatocytes using the fluorescent-labeled bile 
salt cholyl-lysyl-fluorescein (CLF) (Fig. 4). As a consequence, excretion from hepatocytes 
may be induced and de novo synthesis of bile acids reduced as adaptive response. We 
identified the basolateral efflux pump Abcc1 as up-regulated on mRNA level. In rats, an up-
regulation of Abcc1 was reported to occur in hepatocytes after bile duct ligation, which may 
represent an adaptive mechanism of the impaired hepato-biliary excretion of organic anions 
(Pei et al. 2002). However, in contrast to the study of Xiong et al. (2014) dealing with the 
effects of senecionine in rats on bile homeostasis (Xiong et al. 2014), no up-regulation of the 
basolaterally expressed bile acid efflux pump Abcc3 was observed in our study. In the 
present study all bile acid homeostasis-associated genes were down-regulated. This was 




Our study showed severe liver damage in mice including the induction of pericentral necrosis 
and the disturbance of bile acid homeostasis accompanied with induction of inflammatory 
processes. Average human exposure of consumers in Western countries, however, is 
expected to be several orders of magnitude lower than the dose (60 mg senecionine per kg 
BW) used in the present animal study. Total daily human PA intake with normal nutrition was 
estimated to be in median 0.019 µg/kg BW for children and 0.026 µg/kg BW for adults. A high 
uptake was described for the intake of a PA-containing dietary supplements, where a human 
exposure of about 9 µg/kg BW per day was calculated (Dusemund et al. 2018). Thus, the 
present findings should not be viewed as potential risk posed by low dietary exposure in the 
normal population, yet rather considered in the context of acute severe PA poisonings. This 
study substantially contributes to the elucidation of the mode of action of acute intoxication 
with senecionine as a representative of hepatotoxic PAs. 
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